Dr. Neil L Berinstein, MD
Claim this profileStudies Waldenstrom's Macroglobulinemia
Studies Waldenstrom Macroglobulinemia
1 reported clinical trial
3 drugs studied
More about Neil L Berinstein, MD
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Neil L Berinstein, MD has experience with
- Acalabrutinib
- Bendamustine
- Rituximab
Breakdown of trials Neil L Berinstein, MD has run
Waldenstrom's Macroglobulinemia
Waldenstrom Macroglobulinemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Neil L Berinstein, MD specialize in?
Neil L Berinstein, MD focuses on Waldenstrom's Macroglobulinemia and Waldenstrom Macroglobulinemia. In particular, much of their work with Waldenstrom's Macroglobulinemia has involved treating patients, or patients who are undergoing treatment.
Is Neil L Berinstein, MD currently recruiting for clinical trials?
No, Neil L Berinstein, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Neil L Berinstein, MD has studied deeply?
Yes, Neil L Berinstein, MD has studied treatments such as Acalabrutinib, Bendamustine, Rituximab.
What is the best way to schedule an appointment with Neil L Berinstein, MD?
Apply for one of the trials that Neil L Berinstein, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.